PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 27919300
OWN - NLM
STAT- MEDLINE
DCOM- 20180522
LR  - 20180522
IS  - 1601-5215 (Electronic)
IS  - 0924-2708 (Linking)
VI  - 29
IP  - 5
DP  - 2017 Oct
TI  - A randomised, placebo-controlled trial of transcranial pulsed electromagnetic
      fields in patients with multiple chemical sensitivity.
PG  - 267-277
LID - 10.1017/neu.2016.51 [doi]
AB  - OBJECTIVE: To evaluate the efficacy of transcranially applied pulsed
      electromagnetic fields (PEMF) on functional impairments and symptom severity in
      multiple chemical sensitivity (MCS) patients. METHODS: The study was conducted as
      a nationwide trial in Denmark using a randomised, parallel-group, double-blind
      and placebo-controlled design. Sample size was estimated at 40 participants.
      Eligibility criteria were age 18-75 years and fulfilment of the MCS case
      criteria. Participants received either PEMF or placebo PEMF (no stimulation)
      applied transcranially for 6 weeks. The primary outcome was the Life Impact Scale
      (LIS) of the Quick Environmental Exposure and Sensitivity Inventory (QEESI).
      Secondary outcomes were the Symptom Severity Scale (SSS) and the Chemical
      Intolerance Scale of QEESI. RESULTS: A total of 39 participants were randomised
      to PEMF or placebo treatment. No significant difference was observed on QEESI LIS
      between groups with a mean change score of -5.9 in the PEMF group compared with
      -1.5 in the placebo group (p=0.35, effect size=-0.31). However, a significant
      decrease was detected on QEESI SSS within and between groups with a mean change
      score of -11.3 in the PEMF group compared with -3.2 in the placebo group (p=0.03,
      effect size=-0.60). CONCLUSION: PEMF treatment of 6 weeks showed no effect on
      functional impairments in MCS. However, a significant decrease in symptom
      severity was observed.
FAU - Tran, Marie Thi Dao
AU  - Tran MTD
AD  - 1Department of Dermatology and Allergology,Copenhagen University Hospital
      Gentofte,Hellerup,Denmark.
FAU - Skovbjerg, Sine
AU  - Skovbjerg S
AD  - 1Department of Dermatology and Allergology,Copenhagen University Hospital
      Gentofte,Hellerup,Denmark.
FAU - Arendt-Nielsen, Lars
AU  - Arendt-Nielsen L
AD  - 2Department of Health Science and Technology,Center for Sensory-Motor
      Interaction,Aalborg University,Aalborg,Denmark.
FAU - Christensen, Karl Bang
AU  - Christensen KB
AD  - 3Department of Public Health,Section of Biostatistics,University of
      Copenhagen,Copenhagen K,Denmark.
FAU - Elberling, Jesper
AU  - Elberling J
AD  - 1Department of Dermatology and Allergology,Copenhagen University Hospital
      Gentofte,Hellerup,Denmark.
LA  - eng
PT  - Journal Article
PT  - Randomized Controlled Trial
DEP - 20161206
PL  - England
TA  - Acta Neuropsychiatr
JT  - Acta neuropsychiatrica
JID - 9612501
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Double-Blind Method
MH  - Female
MH  - Humans
MH  - *Magnetic Field Therapy
MH  - Male
MH  - Middle Aged
MH  - Multiple Chemical Sensitivity/complications/*therapy
MH  - Severity of Illness Index
MH  - Treatment Outcome
MH  - Young Adult
OTO - NOTNLM
OT  - capsaicin
OT  - multiple chemical sensitivity
OT  - pulsed electromagnetic fields
OT  - randomised trial
OT  - treatment
EDAT- 2016/12/07 06:00
MHDA- 2018/05/23 06:00
CRDT- 2016/12/07 06:00
PHST- 2016/12/07 06:00 [pubmed]
PHST- 2018/05/23 06:00 [medline]
PHST- 2016/12/07 06:00 [entrez]
AID - S092427081600051X [pii]
AID - 10.1017/neu.2016.51 [doi]
PST - ppublish
SO  - Acta Neuropsychiatr. 2017 Oct;29(5):267-277. doi: 10.1017/neu.2016.51. Epub 2016 
      Dec 6.